The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

Hetronifly in combination with chemotherapy was shown to improve survival of patients with extensive stage small cell lung ...

The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) recommended the granting of ...

Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...

The European Medicines Agency approved Afqlir and Opuviz to treat age-related macular degeneration while reiterating its ...

"Although the effect on overall anaemia did not differ, intravenous iron reduced the prevalence of iron deficiency to a ...

The Bruton's tyrosine kinase inhibitor tolebrutinib is reportedly the first agent to show benefit in patients with nonrelapsing secondary progressive MS.

World Patient Safety Day provides an occasion to spread awareness of the medication errors that can result from products that ...

Dermatitis. 2010;21(1):59-60. A 47-year-old female presented for evaluation of a pruritic and painful vulvar dermatitis. The dermatitis began approximately 3 years prior to presentation, shortly ...

A triple advantage can be achieved by shifting Mexicans' current diet toward that of the recommended Healthy and Sustainable ...

Purpose: The stability of a triamcinolone acetonide mouthwash and its efficacy in treating oral lichen planus are described. Results: The mouthwash had a satisfactory shelf life and was well ...